Stock Quote
DexCom, Inc. (DXCM.W) (NASD ADF)
sector: Healthcare .
industry: Medical Equipment, Supplies & Distribution ยท
View DXCM on other exchanges
$7.39
11 Nov 2009
-0.67%
$7.44
$7.44
600
$7.47
$7.36
$8.96
$1.36
1.48
251,184
DXCM.W
More News
| Press Releases
| Key Developments
| Name | Current Position | Compensation |
|---|---|---|
| Lucas, Donald | Chairman of the Board | -- |
| Gregg, Terrance | President, Chief Executive Officer, Director | 2,800,780 |
| Roper, Jess | Chief Financial Officer, Vice President | 310,385 |
Profile
DexCom, Inc. is a medical device company focused on the design, development and commercialization of continuous glucose monitoring systems for ambulatory use by people with diabetes, and for use by healthcare providers in hospitals. On March 24, 2006, it received approval from the Untied States Food... Full Description
Company Address
DexCom, Inc.
5555 Oberlin Drive
San Diego CA 92121
P: +1858.2000200
F: +1858.2000201
5555 Oberlin Drive
San Diego CA 92121
P: +1858.2000200
F: +1858.2000201
Analyst Research
Performance of Key Competitors
| Company | Price | Change |
|---|---|---|
| Roche Holding Ltd. | CHF166.20 | +3.50 |
| Roche Holding Ltd. | CHF169.10 | +1.80 |
| Johnson & Johnson | $62.69 | +0.38 |
| DXCM.W | Industry | |
|---|---|---|
| P/E(TTM) | -- | 3.76 |
| P/S(TTM) | 14.37 | 0.51 |
| ROI(TTM) | -154.73 | 2.54 |
| ROE(TTM) | -- | 4.01 |
| Consensus Recommendation | Outperform |
|---|---|
| EPS Est. (Current Period) | -- |
| EPS Est. (Current Year) | -- |
| Total Revenue | $7.26M |
| Net Income | $-13.52M |
| EPS | $-0.29 |
